Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18960 | 1.00 | — | — | |
| SCHEMBL9232705 | 0.96 | — | — | |
| SCHEMBL9349701 | 0.96 | CHRNA7 (0.32) | CHRNA7 | |
| SCHEMBL6735678 | 0.96 | — | — | |
| Water SCHEMBL1542414 | 0.96 | CHRNA7 (0.32) | CHRNA7 | |
| Bromide SCHEMBL156131 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL2962579 | 0.96 | CHRNA7 (0.32) | CHRNA7 | |
| SCHEMBL538360 | 0.96 | — | — | |
| Fluoride SCHEMBL2112417 | 0.96 | CHRNA7 (0.32) | CHRNA7 | |
| Fluoride SCHEMBL8813655 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3410468-B1 | N-TYPE SEMICONDUCTOR ELEMENT, COMPLEMENTARY TYPE SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME, AND WIRELESS COMMUNICATION DEVICE IN WHICH THE SAME IS USED | TORAY INDUSTRIES (JP) | 2024-07-10 | — | — | EP | disclosed |
| EP-3693290-B1 | PACKING MATERIAL AND METHOD FOR PRODUCING PACKING MATERIAL | TORAY INDUSTRIES (JP) | 2024-01-17 | — | — | EP | disclosed |
| EP-4269023-A1 | POLISHING COMPOSITION | Fujimi Incorporated (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-4195099-A1 | DISCONNECTION DETECTION DEVICE | Toray Industries, Inc. (JP) | 2023-06-14 | — | — | EP | disclosed |
| WO-2023090964-A1 | SILVER PLATING SOLUTION | (주)피이솔브 | 2023-05-25 | — | — | WO | disclosed |
| US-20220177695-A1 | CURABLE COMPOSITION, CURED PRODUCT, FIBER REINFORCED COMPOSITE MATERIAL, AND MOLDED ARTICLE AND METHOD FOR PRODUCING SAME | DIC CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
| US-11274179-B2 | Method for producing compound having amide bond and also having alkoxysilyl group | CANON KABUSHIKI KAISHA (JP) | 2022-03-15 | — | — | US | disclosed |
| EP-3960790-A1 | CURABLE COMPOSITION, CURED PRODUCT, FIBER REINFORCED COMPOSITE MATERIAL, AND MOLDED ARTICLE AND METHOD FOR PRODUCING SAME | DIC Corporation (JP) | 2022-03-02 | — | — | EP | disclosed |
| US-20200339744-A1 | METHOD FOR PRODUCING COMPOUND HAVING AMIDE BOND AND ALSO HAVING ALKOXYSILYL GROUP | CANON KABUSHIKI KAISHA (JP) | 2020-10-29 | — | — | US | disclosed |
| US-20200297700-A1 | BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF | TOBIRA THERAPEUTICS INC (US) | 2020-09-24 | — | — | US | disclosed |
| US-7371772-B2 | Bicyclic compound, production and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-13 | — | — | US | disclosed |
| EP-1889839-A1 | Bicyclic compound, production and use as HIV inhibitors | Takeda Pharmaceutical Company Limited (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-20070208117-A1 | ALUMINUM FINE PARTICLE DISPERSED FILM, COMPOSITION FOR FORMING THE SAME AND METHOD OF FORMING THE SAME | JSR CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| US-20060257667-A1 | Composition for forming silicon-aluminum film, silicon-aluminum film and method for forming the same | JSR CORPORATION (JP) | 2006-11-16 | — | — | US | disclosed |
| US-20060130565-A1 | Measurement of total reactive isocyanate groups in samples using bifunctional nucleophiles such as 1,8-diaminonaphthalene (dan) | THE UNIVERSITY OF MASSACHUSETTS LOWELL RESEARCH FOUNDATION | 2006-06-22 | — | — | US | disclosed |
| US-20050136016-A1 | Hair-relaxing composition comprising at least one base other than hydroxide | L'OREAL S.A. (FR) | 2005-06-23 | — | — | US | disclosed |
| US-20040259876-A1 | Bicyclic compound, production and use thereof | TOBIRA THERAPEUTICS, INC. | 2004-12-23 | — | — | US | disclosed |
| EP-0577788-A1 | INSECT CONTROL WITH SUBSTITUTED OXADIAZOLE AND THIADIAZOLE COMPOUNDS | DOWELANCO (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1993014636-A1 | INSECT CONTROL WITH SUBSTITUTED OXADIAZOLE AND THIADIAZOLE COMPOUNDS | DOWELANCO (US) | 1993-08-05 | — | — | WO | disclosed |
| WO-1990006113-A1 | SUBSTITUTED SATURATED AND UNSATURATED INDOLE QUINOLINE AND BENZAZEPINE CARBOXAMIDES AND THEIR USE AS PHARMACOLOGICAL AGENTS | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1990-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259876-A1 | Bicyclic compound, production and use thereof | CCR5, CCR1, CCR2 | CHRNA7 293/4885 |
| US-20050136016-A1 | Hair-relaxing composition comprising at least one base other than hydroxide | KRT18, H1-0, H1-10 | CHRNA7 552/4885 |
| US-20200297700-A1 | BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF | CCR5, CCR1, CCR2 | CHRNA7 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.